{"description":"Documents matching 'compliance statutory general principles good'","count":10000,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=compliance+statutory+general+principles+good&format=json&page=2","results":[{"title":"M15 General Principles for Model-Informed Drug Development; International Council for Harmonisation; Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled \"M15 General Principles for Model-Informed Drug Development.\" The guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The guidance provides general recommendations for the planning, model evaluation, and documentation of evidence derived from model-informed drug development (MIDD). It establishes a harmonized assessment framework (including the associated terminology) for the MIDD evidence. It also provides recommendations for related regulatory interactions, reporting, and submission. This guideline is intended to facilitate a multidisciplinary understanding of MIDD and associated evidence generation. The guidance finalizes the draft guidance of the same title issued on December 30, 2024.","document_number":"2026-11112","html_url":"https://www.federalregister.gov/documents/2026/06/03/2026-11112/m15-general-principles-for-model-informed-drug-development-international-council-for-harmonisation","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-03/pdf/2026-11112.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-11112.pdf?1780404319","publication_date":"2026-06-03","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"availability. \n \n \n SUMMARY: \n The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled “M15 <span class=\"match\">General</span> <span class=\"match\">Principles</span> for Model-Informed Drug Development.” The guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The guidance provides <span class=\"match\">general</span> recommendations for the planning, model evaluation, and documentation of evidence derived from model-informed drug development (MIDD). It establishes a harmonized"},{"title":"Submission for OMB Review; Comment Request","type":"Notice","abstract":"The Office of the Chief Information Officer, as part of its continuing effort to reduce paperwork and respondent burden, invites the public to comment on the \"Collection of Generic Clearance for Improving Customer Experience (OMB Circular A-11, Section 280 Implementation)\" for approval under the Paperwork Reduction Act. The purpose of this request is to facilitate the Agency's ability to collect feedback from the public to continue to improve its services, thereby facilitating its compliance with statutory requirements and general principles of good governance. This notice announces our intent to submit this collection to Office of Management and Budget (OMB) for approval and solicit comments on specific aspects for the proposed information collection.","document_number":"2026-06756","html_url":"https://www.federalregister.gov/documents/2026/04/08/2026-06756/submission-for-omb-review-comment-request","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-08/pdf/2026-06756.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06756.pdf?1775565915","publication_date":"2026-04-08","agencies":[{"raw_name":"DEPARTMENT OF AGRICULTURE","name":"Agriculture Department","id":12,"url":"https://www.federalregister.gov/agencies/agriculture-department","json_url":"https://www.federalregister.gov/api/v1/agencies/12","parent_id":null,"slug":"agriculture-department"}],"excerpts":"Section 280 Implementation)” for approval under the Paperwork Reduction Act. The purpose of this request is to facilitate the Agency's ability to collect feedback from the public to continue to improve its services, thereby facilitating its <span class=\"match\">compliance</span> with <span class=\"match\">statutory</span> requirements and <span class=\"match\">general</span> <span class=\"match\">principles</span> of <span class=\"match\">good</span> governance. This notice announces our intent to submit this collection to Office of Management and Budget (OMB) for approval and solicit comments on specific aspects for the proposed information collection. \n \n \n DATES: \n Submit comments on"},{"title":"Notice of Information Collection, Request for Comment","type":"Notice","abstract":"The Office of the Chief Information Officer, as part of its continuing effort to reduce paperwork and respondent burden, invites the public to comment on the \"Collection of Generic Clearance for Improving Customer Experience (OMB Circular A-11, Section 280 Implementation)\" for approval under the Paperwork Reduction Act. The purpose of this request is to facilitate the Agency's ability to collect feedback from the public to continue to improve its services, thereby facilitating its compliance with statutory requirements and general principles of good governance. This notice announces our intent to submit this collection to Office of Management and Budget (OMB) for approval and solicit comments on specific aspects for the proposed information collection.","document_number":"2026-01515","html_url":"https://www.federalregister.gov/documents/2026/01/27/2026-01515/notice-of-information-collection-request-for-comment","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-01-27/pdf/2026-01515.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-01515.pdf?1769435116","publication_date":"2026-01-27","agencies":[{"raw_name":"DEPARTMENT OF AGRICULTURE","name":"Agriculture Department","id":12,"url":"https://www.federalregister.gov/agencies/agriculture-department","json_url":"https://www.federalregister.gov/api/v1/agencies/12","parent_id":null,"slug":"agriculture-department"}],"excerpts":"Section 280 Implementation)” for approval under the Paperwork Reduction Act. The purpose of this request is to facilitate the Agency's \n \n ability to collect feedback from the public to continue to improve its services, thereby facilitating its <span class=\"match\">compliance</span> with <span class=\"match\">statutory</span> requirements and <span class=\"match\">general</span> <span class=\"match\">principles</span> of <span class=\"match\">good</span> governance. This notice announces our intent to submit this collection to Office of Management and Budget (OMB) for approval and solicit comments on specific aspects for the proposed information collection.\n \n \n \n DATES: \n Comments on this notice"},{"title":"M14 General Principles on Planning, Designing, Analyzing, and Reporting of Non-Interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines; International Council for Harmonisation; Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled \"General Principles on Planning, Designing, Analyzing, and Reporting of Non- interventional Studies That Utilize Real-World Data for Safety Assessment of Medicines.\" The guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The guidance outlines general principles on planning, designing, analyzing, and reporting non-interventional studies that utilize real-world data for safety assessment of medicines (i.e., drugs, vaccines, and other biological products). The recommendations in this guidance, while focused on safety, are applicable to non-interventional studies assessing effectiveness and are aligned and complementary with the FDA's other guidances on the generation real world evidence. The guidance includes recommendations and high-level best practices for the conduct of these studies, including articulating the research question, selecting appropriate data sources, defining key variables, addressing potential biases and confounding, conducting analyses, reporting, and submission. The guidance is intended to streamline the development and regulatory assessment of postmarketing non-interventional safety studies that include real-world data. The guidance replaces the draft guidance \"M14 General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies that Utilize Real-World Data for Safety Assessment of Medicines\" issued in July 2024. FDA is also announcing the withdrawal of the guidance entitled \"Best Practices for Conducting and Reporting Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data Sets,\" published May 2013.","document_number":"2026-04253","html_url":"https://www.federalregister.gov/documents/2026/03/04/2026-04253/m14-general-principles-on-planning-designing-analyzing-and-reporting-of-non-interventional-studies","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-04/pdf/2026-04253.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-04253.pdf?1772545516","publication_date":"2026-03-04","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"studies. This guidance incorporates the <span class=\"match\">general</span> <span class=\"match\">principles</span> of the May 14, 2013 guidance and is updated to reflect the FDA's current thinking on best practices for conduct and reporting of non-interventional safety studies for medicines. Accordingly, upon publication of this guidance FDA intends to withdraw the May 14, 2013 guidance.\n \n This guidance is being issued consistent with FDA's <span class=\"match\">good</span> guidance practices regulation (21 CFR 10.115). The guidance represents the current thinking of FDA on “M14 <span class=\"match\">General</span> <span class=\"match\">Principles</span> on Planning, Designing, Analyzing,"},{"title":"M15 General Principles for Model-Informed Drug Development; International Council for Harmonisation; Draft Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"M15 General Principles for Model-Informed Drug Development.\" The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The draft guidance discusses the multidisciplinary principles of model-informed drug development (MIDD). This includes recommendations on MIDD planning, model evaluation, and evidence documentation. The draft guidance also includes a harmonized framework for assessing evidence derived from MIDD. The draft guidance is intended to facilitate multidisciplinary understanding, appropriate use, and harmonized assessment of MIDD and its associated evidence.","document_number":"2024-31027","html_url":"https://www.federalregister.gov/documents/2024/12/30/2024-31027/m15-general-principles-for-model-informed-drug-development-international-council-for-harmonisation","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-30/pdf/2024-31027.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-31027.pdf?1735307138","publication_date":"2024-12-30","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"SUMMARY: \n The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “M15 <span class=\"match\">General</span> <span class=\"match\">Principles</span> for Model-Informed Drug Development.” The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The draft guidance discusses the multidisciplinary <span class=\"match\">principles</span> of model-informed drug development (MIDD). This includes recommendations on MIDD planning, model evaluation, and evidence documentation"},{"title":"E22 General Considerations for Patient Preference Studies; International Council for Harmonisation; Draft Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled \"E22 General Considerations for Patient Preference Studies.\" The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). When finalized, this guidance will provide general principles for the use, design, conduct, analysis, and submission of patient preference studies (PPS) aimed at informing drug development, regulatory submission and evaluation, drug approvals, and maintenance of such approvals.","document_number":"2026-02324","html_url":"https://www.federalregister.gov/documents/2026/02/06/2026-02324/e22-general-considerations-for-patient-preference-studies-international-council-for-harmonisation","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-06/pdf/2026-02324.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-02324.pdf?1770299111","publication_date":"2026-02-06","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"\n The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a draft guidance for industry entitled “E22 <span class=\"match\">General</span> Considerations for Patient Preference Studies.” The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). When finalized, this guidance will provide <span class=\"match\">general</span> <span class=\"match\">principles</span> for the use, design, conduct, analysis, and submission of patient preference studies (PPS) aimed at informing drug development, regulatory"},{"title":"Program Fraud Civil Remedies Act Regulations Statutory Updates","type":"Rule","abstract":"The United States Small Business Administration (SBA) is amending the Program Fraud Civil Remedies Act regulations in 13 CFR part 142 to reflect changes made to the Program Fraud Civil Remedies Act of 1986 by the Administrative False Claims Act of 2023. These changes, among other things, revise the name of the administrative action from \"Program Fraud Civil Remedies\" to \"Administrative False Claims\" and increase the threshold for a claim from $150,000 to $1,000,000. The Administrative False Claims Act mandates that the Agency issue regulations to update part 142 and this direct final rule conforms the regulations to the Administrative False Claims Act by adopting the new statutory requirements without change.","document_number":"2026-05459","html_url":"https://www.federalregister.gov/documents/2026/03/19/2026-05459/program-fraud-civil-remedies-act-regulations-statutory-updates","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-19/pdf/2026-05459.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-05459.pdf?1773837923","publication_date":"2026-03-19","agencies":[{"raw_name":"SMALL BUSINESS ADMINISTRATION","name":"Small Business Administration","id":468,"url":"https://www.federalregister.gov/agencies/small-business-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/468","parent_id":null,"slug":"small-business-administration"}],"excerpts":"liability for such penalty or assessment becomes final. \n III. Justification for Direct Final Rule \n In <span class=\"match\">general</span>, SBA publishes a rule for public comment before issuing a final rule in accordance with the Administrative Procedure Act. 5 U.S.C. 553. The Administrative Procedure Act provides an exception to this standard rulemaking process, however, where an agency finds <span class=\"match\">good</span> cause to adopt a rule without prior public participation. 5 U.S.C. 553(b)(B). The <span class=\"match\">good</span> cause requirement is satisfied when prior public participation is impracticable, unnecessary, or"},{"title":"Conformance of Cost Accounting Standards to Generally Accepted Accounting Principles for Operating Revenue and Lease Accounting","type":"Rule","abstract":"The Office of Federal Procurement Policy (OFPP), Cost Accounting Standards Board (the Board), is publishing, with additional clarification based on public comments from the notice of proposed rulemaking (NPRM), a final rule revising the Cost Accounting Standards (CAS) to conform them with changes in Generally Accepted Accounting Principles (GAAP) related to operating revenue and lease accounting. This final rule follows issuance of a NPRM, June 27, 2024; an advanced notice of proposed rulemaking (ANPRM), November, 5, 2020; and a Staff Discussion Paper (SDP), March 13, 2019.","document_number":"2025-17480","html_url":"https://www.federalregister.gov/documents/2025/09/11/2025-17480/conformance-of-cost-accounting-standards-to-generally-accepted-accounting-principles-for-operating","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-09-11/pdf/2025-17480.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-17480.pdf?1757508313","publication_date":"2025-09-11","agencies":[{"raw_name":"OFFICE OF MANAGEMENT AND BUDGET","name":"Management and Budget Office","id":280,"url":"https://www.federalregister.gov/agencies/management-and-budget-office","json_url":"https://www.federalregister.gov/api/v1/agencies/280","parent_id":null,"slug":"management-and-budget-office"},{"raw_name":"Office of Federal Procurement Policy","name":"Federal Procurement Policy Office","id":184,"url":"https://www.federalregister.gov/agencies/federal-procurement-policy-office","json_url":"https://www.federalregister.gov/api/v1/agencies/184","parent_id":280,"slug":"federal-procurement-policy-office"}],"excerpts":"customers, requires an entity to consider whether it is acting as a principal or an agent for each specified <span class=\"match\">good</span> or service promised to a customer. ASC 606-10-55-38 reads as follows: \n \n \n “An entity is an agent if the entity's performance obligation is to arrange for the provision of the specified <span class=\"match\">good</span> or service by another party. An entity that is an agent does not control the specified <span class=\"match\">good</span> or service provided by another party before that <span class=\"match\">good</span> or service is transferred to the customer. When (or as) an entity that is an agent satisfies a performance"},{"title":"Federal “Good Neighbor Plan” for the 2015 Ozone National Ambient Air Quality Standards; Notice on Remand of the Record of the Good Neighbor Plan To Respond to Certain Comments","type":"Rule","abstract":"The Environmental Protection Agency (EPA) is addressing certain comments that were submitted on the proposed Good Neighbor Plan that the Supreme Court of the United States concluded the EPA had likely not sufficiently addressed in the final Good Neighbor Plan. The EPA is providing a fuller explanation of its reasoning at the time of its action in response to these comments. The Good Neighbor Plan addressed 23 states' obligations to eliminate significant contribution to nonattainment or interference with maintenance of the 2015 ozone national ambient air quality standards (NAAQS), pursuant to the \"good neighbor\" provision of the Clean Air Act (CAA or Act). On September 12, 2024, the D.C. Circuit Court of Appeals remanded the record of the Good Neighbor Plan to the EPA to permit the Agency to further respond to comments related to the Good Neighbor Plan's operation if one or more upwind States were no longer participating. In this document, the EPA responds to the comments by more fully explaining why the Good Neighbor Plan appropriately defines each state's obligations, regardless of the status of the rule in other states, and can be implemented without modification in any individual state or combination of states covered by the rule.","document_number":"2024-28739","html_url":"https://www.federalregister.gov/documents/2024/12/10/2024-28739/federal-good-neighbor-plan-for-the-2015-ozone-national-ambient-air-quality-standards-notice-on","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-10/pdf/2024-28739.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-28739.pdf?1733751921","publication_date":"2024-12-10","agencies":[{"raw_name":"ENVIRONMENTAL PROTECTION AGENCY","name":"Environmental Protection Agency","id":145,"url":"https://www.federalregister.gov/agencies/environmental-protection-agency","json_url":"https://www.federalregister.gov/api/v1/agencies/145","parent_id":null,"slug":"environmental-protection-agency"}],"excerpts":"not dependent on the number of states in the <span class=\"match\">Good</span> Neighbor Plan, nor on the order in which the states are addressed. In this way, the <span class=\"match\">Good</span> Neighbor Plan prohibits each covered state's “significant contribution” to downwind ozone problems in a “permissible, workable, and equitable” manner. 572 U.S. at 524.\n \n Given this <span class=\"match\">statutory</span> structure and regulatory framework, the <span class=\"match\">Good</span> Neighbor Plan is “modular” by nature, defining and implementing the obligations for each state. \n \n First, in line with the <span class=\"match\">statutory</span> text, structure, and case law, the EPA determines"},{"title":"M14 General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines; International Council for Harmonisation; Draft Guidance for Industry; Availability","type":"Notice","abstract":"The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled \"M14 General Principles on Plan, Design, and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines.\" The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The draft guidance outlines general principles on planning, designing, and analyzing observational (noninterventional) pharmacoepidemiological studies that utilize fit-for-purpose data for safety assessment of medicines (drugs, vaccines, and other biological products). The draft guidance includes recommendations and high-level best practices for the conduct of these studies. The draft guidance is intended to streamline the development and regulatory assessment of postmarketing pharmacoepidemiological safety studies that include Real-World Data. This guidance also seeks to improve the ability of the study protocol and/or results to be accepted across health authorities and support decision making in response to study results.","document_number":"2024-14717","html_url":"https://www.federalregister.gov/documents/2024/07/05/2024-14717/m14-general-principles-on-plan-design-and-analysis-of-pharmacoepidemiological-studies-that-utilize","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-07-05/pdf/2024-14717.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-14717.pdf?1720010722","publication_date":"2024-07-05","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"excerpts":"(FDA or Agency) is announcing the availability of a draft guidance for industry entitled “M14 <span class=\"match\">General</span> <span class=\"match\">Principles</span> on Plan, Design, and Analysis of Pharmacoepidemiological Studies That Utilize Real-World Data for Safety Assessment of Medicines.” The draft guidance was prepared under the auspices of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The draft guidance outlines <span class=\"match\">general</span> <span class=\"match\">principles</span> on planning, designing, and analyzing observational (noninterventional) pharmacoepidemiological"},{"title":"Meaning of Terms as Used in This Subchapter; Representation Proceedings; National Consultation Rights and Consultation Rights on Government-wide Rules or Regulations; Miscellaneous and General Requirements","type":"Rule","abstract":"The Federal Labor Relations Authority (FLRA) intends to revise the regulations governing representation proceedings, as well as other related regulations, so as to provide parties in most cases with decisions from the Authority on all consequential issues in representation proceedings. Further, these changes will optimize the FLRA's workforce by streamlining the decision-making process in representation proceedings, consistent with E.O. 14,210. The FLRA finds that this interim final rule is not a substantive rule. Certain parts of this interim final rule concern interpretative rules, general statements of policy, or rules of agency organization, procedure, or practice. Other parts of this interim final rule concern minor or technical changes for which good cause exists to make notice and comment unnecessary.","document_number":"2026-05721","html_url":"https://www.federalregister.gov/documents/2026/03/24/2026-05721/meaning-of-terms-as-used-in-this-subchapter-representation-proceedings-national-consultation-rights","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-24/pdf/2026-05721.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-05721.pdf?1774269915","publication_date":"2026-03-24","agencies":[{"raw_name":"FEDERAL LABOR RELATIONS AUTHORITY","name":"Federal Labor Relations Authority","id":176,"url":"https://www.federalregister.gov/agencies/federal-labor-relations-authority","json_url":"https://www.federalregister.gov/api/v1/agencies/176","parent_id":null,"slug":"federal-labor-relations-authority"}],"excerpts":"Authority &amp; Assigned Responsibilities of the <span class=\"match\">General</span> Counsel of the FLRA, \n 48 FR 28814 (June 23, 1983) (amending memorandum so as to delegate authority and responsibility to RDs in representation cases); \n Processing of Cases; <span class=\"match\">General</span> Requirements, \n 48 FR 40189 (Sept. 6, 1983) (revising regulations to implement the amendment to the memorandum). The Authority established a process to review the actions of RDs in those areas of delegated responsibility. \n See \n 5 U.S.C. 7105(f); \n Processing of Cases; <span class=\"match\">General</span> Requirements, \n 48 FR at 40190-95 (establishing"},{"title":"Tribal General Welfare Benefits","type":"Rule","abstract":"This document contains final regulations regarding the exclusion from gross income of certain Tribal general welfare benefits. The regulations address the requirements that apply to determine whether the benefits an Indian Tribal government program provides qualify as Tribal general welfare benefits. These regulations affect Indian Tribal governments, agencies or instrumentalities of such governments, Federally recognized Tribes, members of such Tribes, such members' spouses and dependents, and other Tribal program participants.","document_number":"2025-22873","html_url":"https://www.federalregister.gov/documents/2025/12/16/2025-22873/tribal-general-welfare-benefits","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-12-16/pdf/2025-22873.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-22873.pdf?1765806314","publication_date":"2025-12-16","agencies":[{"raw_name":"DEPARTMENT OF THE TREASURY","name":"Treasury Department","id":497,"url":"https://www.federalregister.gov/agencies/treasury-department","json_url":"https://www.federalregister.gov/api/v1/agencies/497","parent_id":null,"slug":"treasury-department"},{"raw_name":"Internal Revenue Service","name":"Internal Revenue Service","id":254,"url":"https://www.federalregister.gov/agencies/internal-revenue-service","json_url":"https://www.federalregister.gov/api/v1/agencies/254","parent_id":497,"slug":"internal-revenue-service"}],"excerpts":"deferred compensation rules, like constructive receipt, should not apply to deferred <span class=\"match\">general</span> welfare benefits. \n The Treasury Department and the IRS do not agree with the suggestion that Federal income tax <span class=\"match\">principles</span>, such as the constructive receipt doctrine, should be inapplicable to deferred <span class=\"match\">general</span> welfare benefits. The language of section 139E does not provide an exception for treating amounts that, under ordinary Federal income tax <span class=\"match\">principles</span> (such as <span class=\"match\">principles</span> of constructive receipt), are actually or constructively transferred to or for the"},{"title":"Periodic Reporting","type":"Proposed Rule","abstract":"The Commission is acknowledging a recent Postal Service filing requesting the Commission initiate a rulemaking proceeding to consider changes to analytical principles relating to periodic reports. This document informs the public of the filing, invites public comment, and takes other administrative steps.","document_number":"2026-08432","html_url":"https://www.federalregister.gov/documents/2026/04/30/2026-08432/periodic-reporting","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-30/pdf/2026-08432.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-08432.pdf?1777466716","publication_date":"2026-04-30","agencies":[{"raw_name":"POSTAL REGULATORY COMMISSION","name":"Postal Regulatory Commission","id":409,"url":"https://www.federalregister.gov/agencies/postal-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/409","parent_id":null,"slug":"postal-regulatory-commission"}],"excerpts":"to demonstrate <span class=\"match\">compliance</span> with the requirements of [Chapter 37 of Title 39 of the United States Code]. \n \n 39 U.S.C. 3705(a)(1). Upon receiving the Postal Service's report and providing an opportunity for public comment, the Commission must make a written determination of <span class=\"match\">compliance</span>. 39 U.S.C. 3705(e). \n \n Because the PSRA was enacted on April 6, 2022 (during FY 2022 Quarter 3), the Postal Service's first report responsive to this new <span class=\"match\">statutory</span> requirement was due December 29, 2022, covering FY 2022. In its FY 2022 Annual <span class=\"match\">Compliance</span> Determination"},{"title":"Upholding Civil Service Protections and Merit System Principles","type":"Rule","abstract":"The Office of Personnel Management (OPM) is issuing final regulations to reinforce and clarify longstanding civil service protections and merit system principles, codified in law, as they relate to the involuntary movement of Federal employees and positions from the competitive service to the excepted service, or from one excepted service schedule to another. In this final rule, OPM adopts many of the provisions from the proposed rule with some modifications and clarifications based on comments received from the public. The final regulations will better align OPM regulations with relevant statutory text, congressional intent, legislative history, legal precedent, and OPM's longstanding practice.","document_number":"2024-06815","html_url":"https://www.federalregister.gov/documents/2024/04/09/2024-06815/upholding-civil-service-protections-and-merit-system-principles","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-04-09/pdf/2024-06815.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-06815.pdf?1712234712","publication_date":"2024-04-09","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"}],"excerpts":"that congressional intent is not always spelled out in <span class=\"match\">statutory</span> text, especially in a comprehensive statute that deals with many discrete topics. In that situation, courts, regulated entities, and others seeking to interpret <span class=\"match\">statutory</span> language may look to traditional tools of <span class=\"match\">statutory</span> interpretation, including structure, <span class=\"match\">statutory</span> and legislative history and other indicia of intent, as well as relevant precedents. As explained throughout this final rule, these statutes have extensive <span class=\"match\">statutory</span> and legislative history and there are precedents that"},{"title":"Health and Human Services Adoption of the Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards","type":"Rule","abstract":"The Department of Health and Human Services (HHS) adopts with this rule OMB's Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards, to include 12 existing HHS- specific modifications. This rule also repeals HHS' existing regulations governing the administration of HHS financial assistance awards. The existing HHS-specific modifications are described in the rule's preamble. Additionally, the rule will correct citations throughout all relevant HHS regulations.","document_number":"2024-21984","html_url":"https://www.federalregister.gov/documents/2024/10/02/2024-21984/health-and-human-services-adoption-of-the-uniform-administrative-requirements-cost-principles-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-10-02/pdf/2024-21984.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-21984.pdf?1727381768","publication_date":"2024-10-02","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"excerpts":"477; and \n 12. 2 CFR part 300, Appendix IX—<span class=\"match\">Principles</span> for Determining Costs Applicable to Research and Development Under Grants and Contracts with Hospitals, previously codified at 45 CFR part 75, appendix IX. \n \n With these twelve additions, HHS will adopt 2 CFR part 200 in its entirety. Where there are conflicts between OMB and HHS language, HHS adopts the OMB language to ensure consistency and afford recipients the most flexibility and least burden. \n <span class=\"match\">Good</span> Cause Exception \n \n HHS finds there is <span class=\"match\">good</span> cause under 5 U.S.C. 553(b)(B) and (d)(3) to"},{"title":"Corps of Engineers Agency Specific Procedures To Implement the Principles, Requirements, and Guidelines for Federal Investments in Water Resources","type":"Rule","abstract":"This rule establishes Agency Specific Procedures (ASPs) for the U.S. Army Corps of Engineers (Corps) to implement the Principles, Requirements, and Guidelines (PR&G) for Federal water resources investments. It provides a framework to govern how the Corps would evaluate proposed water resources investments, subject to the PR&G. The rule incorporates recommendations from interested parties. The Army is issuing this rule in response to congressional direction in the Water Resources Development Act of 2020.","document_number":"2024-29652","html_url":"https://www.federalregister.gov/documents/2024/12/19/2024-29652/corps-of-engineers-agency-specific-procedures-to-implement-the-principles-requirements-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-12-19/pdf/2024-29652.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-29652.pdf?1734529516","publication_date":"2024-12-19","agencies":[{"raw_name":"DEPARTMENT OF DEFENSE","name":"Defense Department","id":103,"url":"https://www.federalregister.gov/agencies/defense-department","json_url":"https://www.federalregister.gov/api/v1/agencies/103","parent_id":null,"slug":"defense-department"},{"raw_name":"Department of the Army, Corps of Engineers","name":"Engineers Corps","id":142,"url":"https://www.federalregister.gov/agencies/engineers-corps","json_url":"https://www.federalregister.gov/api/v1/agencies/142","parent_id":103,"slug":"engineers-corps"}],"excerpts":"Environmental Policy Act. This paragraph encourages the Corps to integrate the NEPA and the PR&amp;G processes as much as possible to produce a single analytic document to meet both requirements. <span class=\"match\">Compliance</span> under NEPA and this rule does not eliminate the Corps' obligations under other <span class=\"match\">statutory</span> requirements (for example, Endangered Species Act <span class=\"match\">compliance</span>) or fulfillment of Tribal trust responsibilities. \n The Army solicited comment on how the navigation program can use tools and resources to directly assess and, as appropriate, demonstrate project"},{"title":"Performance Appraisal for General Schedule, Prevailing Rate, and Certain Other Employees","type":"Rule","abstract":"The Office of Personnel Management (OPM) is issuing a final rule to increase the efficiency and effectiveness of performance management for non-Senior Executive Service (SES) employees, including General Schedule (GS) and prevailing rate employees. This final rule eliminates unnecessary summary level patterns; removes the prohibition of a forced, or standardized, distribution of performance rating levels; eliminates mandatory review of Level 1 ratings; removes the option to grieve a rating of record; requires a supervisory critical element for all supervisors covered under this subpart; and requires OPM to conduct biennial certifications of agency appraisal systems.","document_number":"2026-13715","html_url":"https://www.federalregister.gov/documents/2026/07/07/2026-13715/performance-appraisal-for-general-schedule-prevailing-rate-and-certain-other-employees","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-07/pdf/2026-13715.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13715.pdf?1783341917","publication_date":"2026-07-07","agencies":[{"raw_name":"OFFICE OF PERSONNEL MANAGEMENT","name":"Personnel Management Office","id":406,"url":"https://www.federalregister.gov/agencies/personnel-management-office","json_url":"https://www.federalregister.gov/api/v1/agencies/406","parent_id":null,"slug":"personnel-management-office"}],"excerpts":"commenter further stated that “Under 5 U.S.C. chapter 43 and established merit system <span class=\"match\">principles</span>, agencies must be able to identify and develop employees whose performance is inadequate but recoverable,” implying that there is a <span class=\"match\">statutory</span> basis for continued use of the Level 2 summary level. \n \n OPM respectfully disagrees. Neither chapter 43 nor the merit system <span class=\"match\">principles</span> require use of a Level 2 summary level or any particular number or naming of summary levels. The <span class=\"match\">statutory</span> obligation to identify, assist, and, where necessary, take action with respect"},{"title":"Extension of Compliance Dates for Nondiscrimination on the Basis of Disability; Accessibility of Web Content and Mobile Applications of Recipients of Departmental Financial Assistance","type":"Rule","abstract":"By this interim final rule (\"IFR\"), the Department of Health and Human Services (\"Department\") is revising the Department's regulations implementing section 504 of the Rehabilitation Act (\"section 504\") to extend the compliance dates for the requirements for web content and mobile application (\"app\") accessibility that were adopted on May 9, 2024. The compliance date for recipients with fifteen (15) or more employees is extended from May 11, 2026, to May 11, 2027. The compliance date for recipients with fewer than fifteen (15) employees is extended from May 10, 2027, to May 10, 2028.","document_number":"2026-09266","html_url":"https://www.federalregister.gov/documents/2026/05/11/2026-09266/extension-of-compliance-dates-for-nondiscrimination-on-the-basis-of-disability-accessibility-of-web","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-05-11/pdf/2026-09266.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-09266.pdf?1778184911","publication_date":"2026-05-11","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"}],"excerpts":"\n \n The Department also responded to commenters seeking different <span class=\"match\">compliance</span> deadlines from those in the NPRM by noting that “changing <span class=\"match\">compliance</span> dates runs the risk of introducing inconsistency with other rulemakings where recipients that are also covered by those rulemakings would be subject to different <span class=\"match\">compliance</span> dates.” \n 68 \n \n Given the short timeframe between DOJ's promulgation of its IFR and the imminent <span class=\"match\">compliance</span> date of the Department's 2024 final rule, there is <span class=\"match\">good</span> cause to dispense with prior notice and comment.\n \n \n \n 65 \n  91 FR"},{"title":"Extension of Compliance Dates for Nondiscrimination on the Basis of Disability; Accessibility of Web Information and Services of State and Local Government Entities","type":"Rule","abstract":"By this Interim Final Rule (\"IFR\"), the Department of Justice (\"Department\") is revising the regulations implementing title II of the Americans with Disabilities Act (\"ADA\") to extend the compliance dates for the requirements for web content and mobile application (\"app\") accessibility that were adopted on April 24, 2024. The compliance date for State and local government entities with a total population of 50,000 or more is extended from April 24, 2026, to April 26, 2027. The compliance date for public entities with a total population of less than 50,000, or any special district government, is extended from April 26, 2027, to April 26, 2028.","document_number":"2026-07663","html_url":"https://www.federalregister.gov/documents/2026/04/20/2026-07663/extension-of-compliance-dates-for-nondiscrimination-on-the-basis-of-disability-accessibility-of-web","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-20/pdf/2026-07663.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-07663.pdf?1776429918","publication_date":"2026-04-20","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"}],"excerpts":"SANPRM, the Department stated that comments submitted in response to the 2010 ANPRM about the suggested <span class=\"match\">compliance</span> dates were “extremely varied,” with recommendations ranging from requiring <span class=\"match\">compliance</span> upon publication of a final rule to allowing a five-year window for <span class=\"match\">compliance</span>, and there was no public consensus.\n 18 \n \n Based on its review of the comments, the Department suggested new potential <span class=\"match\">compliance</span> dates.\n 19 \n \n The potential <span class=\"match\">compliance</span> dates included in the SANPRM ranged from two to three years after the publication of a final rule, depending"},{"title":"General Services Property Management Regulation (GSPMR); Nondiscrimination on the Basis of the Age Act Regulation for Programs or Activities Receiving Federal Financial Assistance","type":"Rule","abstract":"The General Services Administration (GSA) is publishing a rule to migrate, without policy change, GSA's regulations implementing the Age Discrimination Act of 1975 (Age Act), from the government-wide Federal Property Management Regulation (FPMR) to the GSA regulations codified regulations in the General Services Property Management Regulations (GSPMR).","document_number":"2026-04486","html_url":"https://www.federalregister.gov/documents/2026/03/06/2026-04486/general-services-property-management-regulation-gspmr-nondiscrimination-on-the-basis-of-the-age-act","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-06/pdf/2026-04486.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-04486.pdf?1772718319","publication_date":"2026-03-06","agencies":[{"raw_name":"GENERAL SERVICES ADMINISTRATION","name":"General Services Administration","id":210,"url":"https://www.federalregister.gov/agencies/general-services-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/210","parent_id":null,"slug":"general-services-administration"}],"excerpts":"clear authority to conduct <span class=\"match\">compliance</span> reviews, investigate complaints, impose corrective actions, and enforce nondiscrimination requirements on recipients of GSA assistance. Without its own regulation, GSA could not formally impose requirements or take enforcement action to ensure <span class=\"match\">compliance</span>. \n Additionally, GSA's regulation ensures that <span class=\"match\">compliance</span> requirements are tailored to real property, surplus property, and unique GSA assistance programs; processes that align with other GSA civil rights regulations, and <span class=\"match\">compliance</span> procedures that reflect GSA"}]}